Names and Identifiers

• • Mobocertinib
  • mobocertinib (proposed INN)
  • TAK788
  • 39HBQ4A67L
  • GTPL10468
  • BDBM368374
  • US10227342, Example 10
  • example 94 [WO2015195228A1]
  • propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate
  • AP32788
  • Isopropyl 2-((5-acrylamido-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate
  • 1-Methylethyl 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-4-(1-methyl-1H-indo
  • AKOS040759315
  • CS-0114256
  • Mobocertinib(TAK-788)
  • AC-36436
  • XYC46143
  • MOBOCERTINIB [WHO-DD]
  • CHEMBL4650319
  • MFCD32669806
  • EX-A3392
  • TAK-788
  • AP-32788
  • Exkivity
  • TAK 788
  • SY274296
  • Mobocertinib (USAN/INN)
  • NSC-825519
  • propan-2-yl 2-[(4-{[2-(dimethylamino)ethyl](methyl)amino}-2-methoxy-5-(prop-2-enamido)phenyl)amino]-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate
  • MS-30474
  • Mobocertinib [USAN]
  • HY-135815
  • 1-Methylethyl 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-4-(1-methyl-1H-indol-3-yl)-5-pyrimidinecarboxylate
  • DA-55589
  • AT30193
  • EGFR/HER2 Inhibitor TAK-788
  • AP 32788
  • NSC825519
  • Isopropyl 2-(5-acrylamido-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenylamino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate
  • TAK-788;AP32788
  • s6813
  • Mobocertinib [INN]
  • Mobocertinib(TAK-788)?
  • Propan-2-yl 2-(5-(acryloylamino)-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyanilino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate
  • DTXSID201336749
  • 1847461-43-1
  • D12001
  • Mobocertinib (TAK788)
  • BCP31045
  • Mobocertinib [USAN:INN]
  • 5-Pyrimidinecarboxylic acid, 2-((4-((2-(dimethylamino)ethyl)methylamino)-2-methoxy-5-((1-oxo-2-propen-1-yl)amino)phenyl)amino)-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester
  • SCHEMBL17373133
  • isopropyl 2-[(4-{[2-(dimethylamino)ethyl](methyl)amino}-2-methoxy-5-(prop-2-enamido)phenyl)amino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate
  • D81621
  • UNII-39HBQ4A67L
  • example 94 (WO2015195228A1)
  • TAK-788;TAK 788; TAK788; AP32788; AP-32788; AP 32788
  • WHO 11183
  • +expand
• • MDL： MFCD32669806
  • Inchi： 1S/C32H39N7O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26/h9-13,16-20H,1,14-15H2,2-8H3,(H,34,40)(H,33,35,36)
  • InChI Key： AZSRSNUQCUDCGG-UHFFFAOYSA-N
  • SMILES： O(C([H])([H])[H])C1C([H])=C(C(=C([H])C=1N([H])C1=NC([H])=C(C(=O)OC([H])(C([H])([H])[H])C([H])([H])[H])C(C2=C([H])N(C([H])([H])[H])C3=C([H])C([H])=C([H])C([H])=C23)=N1)N([H])C(C([H])=C([H])[H])=O)N(C([H])([H])[H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]

Computed Properties

Experimental Properties